Suchergebnisse - "Antiviral Agents"

PubPharm (106.391)

91

Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection

enthalten in: Journal of virology | 2024

von Huang, Y. | Cheng, T. | Wang, Y. | +7

92

Differential Interactions of the Proteasome Inhibitor PI31 with Constitutive and Immuno-20S Proteasomes

enthalten in: Biochemistry | 2024

von Wang, J. | Kjellgren, A. | DeMartino, G.

93

Real-world safety and effectiveness of tenofovir alafenamide for 144 weeks in Japanese patients with chronic hepatitis B

enthalten in: Journal of viral hepatitis | 2024

von Hige, S. | Aoki, K. | Nakamoto, D. | +8

94

Low-Temperature Adaptive Single-Atom Iron Nanozymes against Viruses in the Cold Chain

enthalten in: Advanced materials (Deerfield Beach, Fla.) | 2024

von Qin, T. | Chen, Y. | Miao, X. | +10

95

An unusual co-reactivation of herpes genitalis and shingles in a young male with primary genital herpes in partner

enthalten in: International journal of STD & AIDS | 2024

von Sadhukhan, S. | Patra, S. | Gadepalli, R. | +1

96

Population Pharmacokinetics of Nirsevimab in Preterm and Term Infants

enthalten in: Journal of clinical pharmacology | 2024

von Clegg, L. | Freshwater, E. | Leach, A. | +2

97

Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2024

von Berentschot, J. | Martine Bek, L. | Heijenbrok-Kal, M. | +5

98

Identification of putative antiviral bioactive compounds derived from family Asteraceae : An in silico approach

enthalten in: Journal of cellular biochemistry | 2024

von Srivastava, S. | Khan, M. | Ahmad, S. | +3

99

Toward hepatitis C virus elimination using artificial intelligence

enthalten in: Clinical and molecular hepatology | 2024

von Hur, M. | Lee, J.

CommentOn: Clin Mol Hepatol. 2024 Jan;30(1):64-79. - PMID 38195113

100

Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CLpro inhibitors

enthalten in: International journal of biological macromolecules | 2024

von Wang, F. | Liu, D. | Gao, D. | +7